Human biodistribution and dosimetry of the PET perfusion agent copper- 62-PTSM

Journal of Nuclear Medicine

Volumn 39, Issue 11, 1998, Pages 1958-1964

  Wallhaus, Thomas R ^a   Lacy, Jeffrey ^b   Whang, Jean ^b   Green, Mark A ^b   Nickles, Robert J ^b   Stone, Charles K ^b  

^a University of Wisconsin Health   (United States)

^b NONE

Author keywords

Copper 62 pyruvaldehyde bis(N4 methyl)thiosemicarbazone; Dosimetry; PET

Indexed keywords

COPPER 62;

ARTICLE; DOSE TIME EFFECT RELATION; DOSIMETRY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG SAFETY; DRUG URINE LEVEL; HALF LIFE TIME; HUMAN; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; COPPER; COPPER RADIOISOTOPES; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; RADIOMETRY; RADIONUCLIDE GENERATORS; RADIOPHARMACEUTICALS; THIOSEMICARBAZONES; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031773749     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Robinson GD, Zielinski FW, Lee AW. Zn-62/Cu-62 generator: A convenient source of copper-62 radiopharmaceuticals. Int J Appl Radiat Isot 1980;31:111-116.
2. Robinson GD. Cyclotron-related radiopharmaceutical development program at UCLA. Prog Nucl Med 1978;4:80-82.
3. Thakur ML, Nunn AD. Preparation of carrier-free zinc-62 for medical use. Radiochem Radioanal Lett 1969;2:301-306.
4. Veda N, Nakamoto S, Tanaka Y, et al. Production of Zn-62 and development of Zn-62/Cu-62 generator system [Abstract]. J Nucl Med 1983;24:P124.
5. Yagi M, Kondo K. A Cu-62 generator. Int J Appl Radiat Isot 1979;30:569-570.
6. Green MA, Klippenstein DL, Tennison JR Copper (II) bis (thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. J Nucl Med 1988;29:1549-1557.
7. 4-methylthiosemicarbazone) copper (II): Synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med 1990;31:1989-1996.
8. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. Kinetics of copper-PTSM in isolated heart: A novel tracer for measuring blood flow with positron emission tomography. J Nucl Med 1989;30:1843-1847.
9. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Circulation 1990;82:990-997.
10. Mathias CJ, Welch MJ, Raichle ME, et al. Evaluation of a potential generator produced PET tracer for cerebral perfusion imaging: Single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM. J Nucl Med 1990;31:351-359.
11. 62Cu-PTSM and positron emission tomography. Circulation 1993;87:173-183.
12. Bergmann SR, Weinheimer CJ, Herrero P, et al. Measurement of myocardial perfusion with positron emission tomography and generator produced copper-62-PTSM [Abstract]. J Am Coll Cardiol 1990;15:80A.
13. Beanlands RS, Muzik O, Mintun M, et al. The kinetics of copper-62-PTSM in the normal human heart. J Nucl Med 1992;33:684-690.
14. Stone CK, Martin CC, Mueller B, Pyzalski RA, Perlman SB, Nickles RJ. Comparison of myocardial uptake of copper pyruvaldehyde thiosemicarbazone with N-13 ammonia in humans by PET. Circulation 1991;32(suppl):999.
15. Tadamura E, Tamaki N, Kawamoto M, et al. Value and limitation of copper-62 pyruvaldehyde bis methylthiosemicarbazone as a myocardial perfusion tracer for PET. J Nucl Med 1994;35(suppl):156P.
16. Herrero P, Hartman JJ, Green MA, Anderson CJ, Welch MJ, Markham J, Bergmann SR. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. J Nucl Med 1996;37:1294-1300.
17. Okazawa H, Yonekura Y, Fujibayashi Y, et al. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET. J Nucl Med 1994;35:1910-1915.
18. Lacy JL, Chien SC, Lim JK, Mathias CJ, Green MA. Modular automated Zn-62/Cu-62 PET radiopharmaceutical generator [Abstract]. J Nucl Med 1995;36:49P.
19. Lacy JL, Rau V, John E, Green MA. Cu-62-PTSM and related bis (thiosemicarbazone) complexes produced by an automated Zn-62/Cu-62 generator for myocardial PET perfusion imaging [Abstract]. J Nucl Med 1996;37:308P.
20. Snyder WS, Cook MJ, Nasset ES, Karhausen LR, Howells GP, Tipton IH. ICRP No. 23. Report of the task group on reference man. New York: Pergamon Press: 1975;280-281.
21. Loevinger R, Budinger TF, Evelyn EW. MIRD primer for absorbed dose calculations. New York: The Society of Nuclear Medicine; 1991.
22. MIRDOSE 3.1 Program. Oak Ridge, TN: Oak Ridge Associated Universities; 1994.
23. Eckerman KF, Christy M. Specific absorbed fractions of energy at various ages from internal photon sources. Document #ORNL/Tm-8381. Oak Ridge, TN: Oak Ridge National Laboratory; 1987:1-8.
24. 67Cu-labeled Cu-PTSM. Nucl Med Biol 1992;19:697-701.
25. 4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: A novel radiopharmaceutical for positron emission imaging. Ann Nucl Med 1995;9:1-5.
26. 4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependant reduction by complex I in brain mitochondria: A potential radiopharmaceutical for mitochondrial functional imaging with positron emission tomography. Bio Pharm Bull 1995;18:1126-1129.
27. Mathias CJ, Bergmann SR, Green MA. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to scrum albumin. J Nucl Med 1995;36: 1451-1455.
28. Schwarz SW, Eichling JO, Welch MJ. Considerations necessary for determining radiation dosimetry of positron emitting radiopharmaceuticals. J Lab Comp Radiopharm 1994;35:603-604.
29. Owen CA. Biochemical aspects of copper. Park Ridge, NJ: Noyes Publications; 1982;177-181.
30. Cardiolite package insert. The DuPont Merck Pharmaceutical Company, January 1996.
31. Huda W, Sandison GA. The use of the effective dose equivalent, HE, as a risk parameter in computed tomography. Br J Radiol 1986;59:1236-1238.
32. Deloar HM, Shidahara M, Fujiwara T, Nakamura T, Miyake M, Satanuki S, Itoh M. Radiation absorbed dose estimates for 2-[F-18]Fluoro-2-deoxy-D-glucose by using whole body PET and MRI [Abstract]. J Nucl Med 1997;38:225P.
33. Stone CK, Christian BT, Nickles RJ, Perlman SB. Technetium-94m methoxy isobutyl isonitrile: Dosimetry and resting cardiac imaging with positron emission tomography. J Nucl Cardiol 1994;1:425-33.